INDIANAPOLIS, May 28, 2020 /PRNewswire/ -- Beckman Coulter
Life Sciences today announced RNAdvance Viral XP has been
added to the list of acceptable extraction methods for use in the
Centers for Disease Control's EUA-authorized COVID-19 test
referenced in the FDA's FAQ on testing for SARS-CoV-2. Laboratories
are now permitted to independently validate RNAdvance Viral XP for
use.
The extraction of RNA from viral samples is a critical step for
pathogen research and detection to enable accurate downstream assay
results. Beckman Coulter Life Sciences has remained committed to
developing high-performing, scalable reagents for laboratories
testing COVID-19 patient swab samples.
"RNA extraction is essential today for reliable COVID-19
testing," said Thomas Marshall,
Ph.D., Genomics R&D Leader, Beckman Coulter Life Sciences. "RNA
extraction removes contaminants from the sample, which can
interfere with the qRT-PCR test and result in a false
negative."
In March, Beckman Coulter Life Sciences published two
demonstrated RNA extraction methods for viral samples. Then,
earlier this month, the company formally launched RNAdvance Viral
XP as a reagent kit for research use.
"Our team has worked diligently with customers and government
entities to develop, refine and validate proven viral extraction
reagents during this time of increased need," said
Greg Milosevich, President, Beckman
Coulter Life Sciences. "The entire Beckman Coulter Life Sciences
family is proud our technology can now be used to expand COVID-19
testing capabilities in laboratories around the world for the
foreseeable future."
Beckman Coulter Life Sciences is an operating company within
Danaher Corporation's (NYSE: DHR) Life Sciences platform. For more
information about RNAdvance Viral XP,
visit beckman.com/reagents/genomic/rna-isolation/viral. Follow
@Beckman Coulter Life Sciences on LinkedIn for real-time
updates and insights across the business.
RNAdvance Viral XP is listed as an extraction method for use
with the Centers for Disease Control's EUA-authorized COVID-19 test
referenced in FDA's FAQ on testing for SARS-CoV-2. Other than
this designation, RNAdvance Viral XP is for research use, and not
intended for diagnostic purposes.
About Beckman Coulter Life Sciences
Life sciences. Research. Precision manufacturing. If your life's
calling is in any of these or related fields, you need to know
Beckman Coulter Life Sciences. Since 1935, the Beckman name has
been synonymous with technologies that simplify and automate
complex biomedical testing. Decades later, our global organization
also came to embody the scientific legacy of the Coulter name.
Today, Beckman Coulter Life Sciences is a trusted, worldwide
resource for tools to help optimize research and manufacturing
efficiency. Centrifuges. Particle counters/analyzers. Automated
liquid handlers. Flow cytometers. All these products—and many
more—continue to make a difference in people's lives by improving
the productivity of dedicated scientists, quality control experts
and others. From prestigious universities and major pharmaceutical
companies, to small biotech startups, food/beverage and electronics
manufacturing facilities, you can find our name virtually
everywhere. For more details, visit beckman.com.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/fda-lists-beckman-coulter-life-sciences-rna-extraction-kit-for-use-in-eua-authorized-covid-19-test-301067149.html
SOURCE Beckman Coulter Life Sciences